The coordinated activation of PI3K/AKT and NF-κB Signaling can drive the malignant progression of multiple tumors including CRC (Ahmad et al. 2013), and these pathways are important targets for anti-cancer therapy. This evidence concerns the gene NFKB1 and colorectal carcinoma.